Clinical Trials · NCT06924697
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
- Phase
- N/A
- Recruitment status
- Enrolling By Invitation
- Sponsor
- Shanghai East Hospital
- Enrollment
- 46
- Start date
- Jun 2025
- Locations
- 1 site, China
- Primary endpoint
- Fagerstrom Test of Nicotine Dependence (FTND) scores